drugset / Trial / NCT03951194
Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
Phase 2/3
Recruiting
100 enrolled
Genesis Athens Clinic
National and Kapodistrian University of Athens · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Autologous PRP intra ovarian infusion may improve ovarian response and women's hormonal profile and may promote folliculogenesis in perimenopausal women.
Timeline
- Start
- 2019-06-13
- Primary completion
- 2027-01-30
- Completion
- 2028-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRP | Unknown | — | Other |